z-logo
open-access-imgOpen Access
Infliximab-Associated Psoriasis in Children With Crohn’s Disease May Require Withdrawal of Anti–Tumor Necrosis Factor Therapy
Author(s) -
Tangra Broge,
Nam Q. Nguyen,
Alan I. Sacks,
Michael K. Davis
Publication year - 2013
Publication title -
inflammatory bowel diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.932
H-Index - 146
eISSN - 1536-4844
pISSN - 1078-0998
DOI - 10.1097/mib.0b013e3182802c93
Subject(s) - infliximab , medicine , psoriasis , tumor necrosis factor alpha , crohn's disease , tumor necrosis factor α , disease , dermatology , inflammatory bowel disease , necrosis , gastroenterology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom